Adare Pharma Solutions
Adare Pharma Solutions, headquartered in the United States, is a leading provider in the pharmaceutical industry, specialising in advanced drug delivery systems and formulation development. Founded in 2014, the company has rapidly established itself as a key player in the market, with a focus on enhancing the bioavailability and stability of complex molecules. With operational facilities across North America and Europe, Adare Pharma Solutions offers a diverse range of services, including customised formulation development, manufacturing, and packaging solutions. Their unique expertise in oral and topical dosage forms sets them apart, enabling clients to bring innovative therapies to market efficiently. Recognised for their commitment to quality and innovation, Adare Pharma Solutions has achieved significant milestones, positioning themselves as a trusted partner for pharmaceutical companies seeking to optimise their product offerings.
DitchCarbon Score
How does Adare Pharma Solutions's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Adare Pharma Solutions's score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Adare Pharma Solutions's reported carbon emissions
Adare Pharma Solutions, headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor does it report any specific reduction targets or climate commitments. The absence of emissions data suggests that the company may still be in the early stages of developing its sustainability strategy or reporting framework. As of now, there are no inherited emissions data or climate initiatives cascaded from a parent organisation, indicating that Adare Pharma Solutions operates independently in this regard. The company has not publicly committed to any specific science-based targets or climate pledges, which are increasingly becoming standard in the pharmaceutical industry. In the context of the industry, many companies are actively working towards reducing their carbon footprints and setting ambitious targets to align with global climate goals. Adare Pharma Solutions may need to consider establishing measurable climate commitments to enhance its sustainability profile and meet stakeholder expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Adare Pharma Solutions is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
